[1] |
LI Mingying, ZHANG Xiaoxia, SUN Xiaoli, ZHAO Yan, HE Miao, LI Yanling, DUAN Wei, YANG Ou.
Effect of Sugammadex on Recovery of Patients after Laparoscopic Total Pelvic Floor Reconstruction
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 896-901.
|
[2] |
ZHAO Jie, GAO Minge, CHANG Hong, FAN Huixia.
Pathogen Distribution, Drug Resistance and Drug Use in Neonates with Necrotizing Enterocolitis Complicated with Sepsis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 909-913.
|
[3] |
SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui.
Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
|
[4] |
YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan.
Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
|
[5] |
KE Xiuqin, HAI Xuewu.
433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
|
[6] |
LIANG Jie.
172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
|
[7] |
LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji.
Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
|
[8] |
YANG Xin, YANG Baochun, YANG Yang, SHAO Huan.
One Case of Multiple Endocrine Adverse Effect Caused by Sintilimab
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 947-949.
|
[9] |
WANG Chunting, CHEN Yafei.
Considerations for Revision of Safety Information in the Post-Marketing Instructions of Chemical Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 776-779.
|
[10] |
LI Dong, SONG Yana, WANG Ligang, BIAN Rongrong, ZHAO Yan.
Considerations for Establishing National Sentinel Hospitals for Medical Device Adverse Event Monitoring
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 780-785.
|
[11] |
ZHU Huijuan, REN Jingtian.
Safety Risks of Human Rabies Immunoglobulin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 786-789.
|
[12] |
CHEN Yaozhe, ZHAN Yunli, SONG Xingdong, ZHU Manyu, OU Xuemei, LI Chuyun.
48 Cases of Hematological Adverse Reactions Associated with Piperacillin Sodium and Tazobactam Sodium
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 794-798.
|
[13] |
CAO Kai, QIAN Peipei, GAO Xin, YANG Futian, ZHAO Liang, XU Bingxin, ZHANG Xianjun.
Mining of Risk Signals Adverse Events Related to Drug-Induced Salivary Gland Calculus Based on FAERS Database
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 799-804.
|
[14] |
LEI Jianlin, WANG Na, WANG Wenzheng, WANG Yan.
One Case of Phenytoin Intoxication Caused by Compound Phenytoin Sodium Ephedrine Hydrochloride and Theophylline Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 819-822.
|
[15] |
LI Min, LI Chunlei, SUN Cuicui, YU Wenwen, SUN Qing, QI Yingmei, LIU Anchang.
One Case of Acute Generalized Exanthematous Pustulosis Caused by Abrocitinib Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 823-825.
|